HEADER CHAPERONE 22-JAN-20 6LTK TITLE HSP90 IN COMPLEX WITH SNX-2112 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HEAT SHOCK 86 KDA,HSP86,LIPOPOLYSACCHARIDE-ASSOCIATED COMPND 5 PROTEIN 2,LPS-ASSOCIATED PROTEIN 2,RENAL CARCINOMA ANTIGEN NY-REN-38; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSP90AA1, HSP90A, HSPC1, HSPCA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS HSP90, SNX-2112, CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR H.L.CAO REVDAT 3 29-NOV-23 6LTK 1 REMARK REVDAT 2 11-AUG-21 6LTK 1 JRNL REVDAT 1 27-JAN-21 6LTK 0 JRNL AUTH D.ZHAO,Y.M.XU,L.Q.CAO,F.YU,H.ZHOU,W.QIN,H.J.LI,C.X.HE, JRNL AUTH 2 L.XING,X.ZHOU,P.Q.LI,X.JIN,Y.HE,J.H.HE,H.L.CAO JRNL TITL COMPLEX CRYSTAL STRUCTURE DETERMINATION AND IN VITRO JRNL TITL 2 ANTI-NON-SMALL CELL LUNG CANCER ACTIVITY OF HSP90 N JRNL TITL 3 INHIBITOR SNX-2112. JRNL REF FRONT CELL DEV BIOL V. 9 50106 2021 JRNL REFN ESSN 2296-634X JRNL PMID 33855025 JRNL DOI 10.3389/FCELL.2021.650106 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 16746 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1675 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.2370 - 4.8977 0.98 1324 149 0.1812 0.2005 REMARK 3 2 4.8977 - 3.8889 0.99 1282 140 0.1603 0.2051 REMARK 3 3 3.8889 - 3.3977 1.00 1263 148 0.1799 0.2166 REMARK 3 4 3.3977 - 3.0873 1.00 1274 137 0.2025 0.2025 REMARK 3 5 3.0873 - 2.8661 1.00 1261 135 0.2055 0.2406 REMARK 3 6 2.8661 - 2.6972 0.98 1225 152 0.2200 0.2855 REMARK 3 7 2.6972 - 2.5621 1.00 1265 122 0.2210 0.2676 REMARK 3 8 2.5621 - 2.4506 1.00 1254 148 0.2275 0.2562 REMARK 3 9 2.4506 - 2.3563 1.00 1231 144 0.2309 0.2688 REMARK 3 10 2.3563 - 2.2750 1.00 1265 127 0.2324 0.2816 REMARK 3 11 2.2750 - 2.2039 1.00 1226 154 0.2545 0.3059 REMARK 3 12 2.2039 - 2.1410 0.95 1201 119 0.2518 0.2896 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.780 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 1697 REMARK 3 ANGLE : 0.707 2295 REMARK 3 CHIRALITY : 0.045 260 REMARK 3 PLANARITY : 0.003 289 REMARK 3 DIHEDRAL : 9.680 1014 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6LTK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 23-JAN-20. REMARK 100 THE DEPOSITION ID IS D_1300015431. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16858 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3TUH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL (PH 8.5) 200 MM MGCL2 REMARK 280 25% PEG4000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.85000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 44.43400 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 48.27500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.85000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 44.43400 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 48.27500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.85000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 44.43400 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 48.27500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.85000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 44.43400 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 48.27500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 SER A -8 REMARK 465 SER A -7 REMARK 465 GLY A -6 REMARK 465 VAL A -5 REMARK 465 ASP A -4 REMARK 465 LEU A -3 REMARK 465 GLY A -2 REMARK 465 THR A -1 REMARK 465 GLU A 0 REMARK 465 ASN A 1 REMARK 465 LEU A 2 REMARK 465 TYR A 3 REMARK 465 PHE A 4 REMARK 465 GLN A 5 REMARK 465 SER A 6 REMARK 465 ASN A 7 REMARK 465 ALA A 8 REMARK 465 ASP A 9 REMARK 465 GLN A 10 REMARK 465 PRO A 11 REMARK 465 MET A 12 REMARK 465 GLU A 13 REMARK 465 GLU A 14 REMARK 465 GLU A 15 REMARK 465 GLU A 16 REMARK 465 GLU A 225 REMARK 465 ARG A 226 REMARK 465 ASP A 227 REMARK 465 LYS A 228 REMARK 465 GLU A 229 REMARK 465 VAL A 230 REMARK 465 SER A 231 REMARK 465 ASP A 232 REMARK 465 ASP A 233 REMARK 465 GLU A 234 REMARK 465 ALA A 235 REMARK 465 GLU A 236 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O ALA A 21 NZ LYS A 224 8555 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 105 -60.16 -124.84 REMARK 500 ALA A 166 -145.57 61.05 REMARK 500 ARG A 182 135.20 -170.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E0G A 301 DBREF 6LTK A 9 236 UNP P07900 HS90A_HUMAN 9 236 SEQADV 6LTK MET A -15 UNP P07900 INITIATING METHIONINE SEQADV 6LTK HIS A -14 UNP P07900 EXPRESSION TAG SEQADV 6LTK HIS A -13 UNP P07900 EXPRESSION TAG SEQADV 6LTK HIS A -12 UNP P07900 EXPRESSION TAG SEQADV 6LTK HIS A -11 UNP P07900 EXPRESSION TAG SEQADV 6LTK HIS A -10 UNP P07900 EXPRESSION TAG SEQADV 6LTK HIS A -9 UNP P07900 EXPRESSION TAG SEQADV 6LTK SER A -8 UNP P07900 EXPRESSION TAG SEQADV 6LTK SER A -7 UNP P07900 EXPRESSION TAG SEQADV 6LTK GLY A -6 UNP P07900 EXPRESSION TAG SEQADV 6LTK VAL A -5 UNP P07900 EXPRESSION TAG SEQADV 6LTK ASP A -4 UNP P07900 EXPRESSION TAG SEQADV 6LTK LEU A -3 UNP P07900 EXPRESSION TAG SEQADV 6LTK GLY A -2 UNP P07900 EXPRESSION TAG SEQADV 6LTK THR A -1 UNP P07900 EXPRESSION TAG SEQADV 6LTK GLU A 0 UNP P07900 EXPRESSION TAG SEQADV 6LTK ASN A 1 UNP P07900 EXPRESSION TAG SEQADV 6LTK LEU A 2 UNP P07900 EXPRESSION TAG SEQADV 6LTK TYR A 3 UNP P07900 EXPRESSION TAG SEQADV 6LTK PHE A 4 UNP P07900 EXPRESSION TAG SEQADV 6LTK GLN A 5 UNP P07900 EXPRESSION TAG SEQADV 6LTK SER A 6 UNP P07900 EXPRESSION TAG SEQADV 6LTK ASN A 7 UNP P07900 EXPRESSION TAG SEQADV 6LTK ALA A 8 UNP P07900 EXPRESSION TAG SEQRES 1 A 252 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 252 GLY THR GLU ASN LEU TYR PHE GLN SER ASN ALA ASP GLN SEQRES 3 A 252 PRO MET GLU GLU GLU GLU VAL GLU THR PHE ALA PHE GLN SEQRES 4 A 252 ALA GLU ILE ALA GLN LEU MET SER LEU ILE ILE ASN THR SEQRES 5 A 252 PHE TYR SER ASN LYS GLU ILE PHE LEU ARG GLU LEU ILE SEQRES 6 A 252 SER ASN SER SER ASP ALA LEU ASP LYS ILE ARG TYR GLU SEQRES 7 A 252 SER LEU THR ASP PRO SER LYS LEU ASP SER GLY LYS GLU SEQRES 8 A 252 LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN ASP ARG THR SEQRES 9 A 252 LEU THR ILE VAL ASP THR GLY ILE GLY MET THR LYS ALA SEQRES 10 A 252 ASP LEU ILE ASN ASN LEU GLY THR ILE ALA LYS SER GLY SEQRES 11 A 252 THR LYS ALA PHE MET GLU ALA LEU GLN ALA GLY ALA ASP SEQRES 12 A 252 ILE SER MET ILE GLY GLN PHE GLY VAL GLY PHE TYR SER SEQRES 13 A 252 ALA TYR LEU VAL ALA GLU LYS VAL THR VAL ILE THR LYS SEQRES 14 A 252 HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SER SER ALA SEQRES 15 A 252 GLY GLY SER PHE THR VAL ARG THR ASP THR GLY GLU PRO SEQRES 16 A 252 MET GLY ARG GLY THR LYS VAL ILE LEU HIS LEU LYS GLU SEQRES 17 A 252 ASP GLN THR GLU TYR LEU GLU GLU ARG ARG ILE LYS GLU SEQRES 18 A 252 ILE VAL LYS LYS HIS SER GLN PHE ILE GLY TYR PRO ILE SEQRES 19 A 252 THR LEU PHE VAL GLU LYS GLU ARG ASP LYS GLU VAL SER SEQRES 20 A 252 ASP ASP GLU ALA GLU HET E0G A 301 33 HETNAM E0G 4-[6,6-DIMETHYL-4-OXIDANYLIDENE-3-(TRIFLUOROMETHYL)-5, HETNAM 2 E0G 7-DIHYDROINDAZOL-1-YL]-2-[(4-OXIDANYLCYCLOHEXYL) HETNAM 3 E0G AMINO]BENZAMIDE FORMUL 2 E0G C23 H27 F3 N4 O3 FORMUL 3 HOH *47(H2 O) HELIX 1 AA1 GLN A 23 THR A 36 1 14 HELIX 2 AA2 GLU A 42 LEU A 64 1 23 HELIX 3 AA3 THR A 65 ASP A 71 5 7 HELIX 4 AA4 THR A 99 ASN A 105 1 7 HELIX 5 AA5 ASN A 105 GLY A 125 1 21 HELIX 6 AA6 ASP A 127 GLY A 135 5 9 HELIX 7 AA7 VAL A 136 LEU A 143 5 8 HELIX 8 AA8 GLU A 192 LEU A 198 5 7 HELIX 9 AA9 GLU A 199 SER A 211 1 13 SHEET 1 AA1 8 GLU A 18 ALA A 21 0 SHEET 2 AA1 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 AA1 8 TYR A 160 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 AA1 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 AA1 8 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 AA1 8 THR A 88 ASP A 93 -1 N LEU A 89 O LEU A 188 SHEET 7 AA1 8 ILE A 78 ASN A 83 -1 N ASN A 79 O VAL A 92 SHEET 8 AA1 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SITE 1 AC1 13 SER A 52 ALA A 55 LYS A 58 ASP A 93 SITE 2 AC1 13 LEU A 107 ALA A 111 GLY A 135 TYR A 139 SITE 3 AC1 13 TRP A 162 THR A 184 HOH A 417 HOH A 424 SITE 4 AC1 13 HOH A 441 CRYST1 69.700 88.868 96.550 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014347 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011253 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010357 0.00000